- Home
- HIMS vs BAX Comparison
HIMS vs BAX Comparison
Compare HIMS & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIMS
- BAX
- Stock Information
- Founded
- HIMS 2017
- BAX 1931
- Country
- HIMS United States
- BAX United States
- Employees
- HIMS N/A
- BAX N/A
- Industry
- HIMS Medical/Nursing Services
- BAX Medical/Dental Instruments
- Sector
- HIMS Health Care
- BAX Health Care
- Exchange
- HIMS Nasdaq
- BAX Nasdaq
- Market Cap
- HIMS 10.8B
- BAX 12.4B
- IPO Year
- HIMS N/A
- BAX N/A
- Fundamental
- Price
- HIMS $56.17
- BAX $23.69
- Analyst Decision
- HIMS Hold
- BAX Hold
- Analyst Count
- HIMS 11
- BAX 9
- Target Price
- HIMS $37.20
- BAX $32.00
- AVG Volume (30 Days)
- HIMS 28.3M
- BAX 6.0M
- Earning Date
- HIMS 11-03-2025
- BAX 11-07-2025
- Dividend Yield
- HIMS N/A
- BAX 2.87%
- EPS Growth
- HIMS 866.21
- BAX N/A
- EPS
- HIMS 0.79
- BAX N/A
- Revenue
- HIMS $2,013,538,000.00
- BAX $10,887,000,000.00
- Revenue This Year
- HIMS $61.80
- BAX $7.38
- Revenue Next Year
- HIMS $19.38
- BAX $3.78
- P/E Ratio
- HIMS $71.21
- BAX N/A
- Revenue Growth
- HIMS 88.69
- BAX 3.60
- 52 Week Low
- HIMS $15.73
- BAX $21.33
- 52 Week High
- HIMS $72.98
- BAX $40.05
- Technical
- Relative Strength Index (RSI)
- HIMS 61.73
- BAX 44.12
- Support Level
- HIMS $48.69
- BAX $23.10
- Resistance Level
- HIMS $56.52
- BAX $24.11
- Average True Range (ATR)
- HIMS 3.44
- BAX 0.65
- MACD
- HIMS 1.11
- BAX 0.03
- Stochastic Oscillator
- HIMS 97.78
- BAX 36.42
About HIMS Hims & Hers Health Inc.
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.